IL-12 Antagonism Induces T Helper 2 Responses, yet Exacerbates Cardiac Allograft Rejection: Evidence Against a Dominant Protective Role for T Helper 2 Cytokines in Alloimmunity

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 1951-1957

  Piccotti, Joseph R ^a   Chan, Sherri Y ^a   Goodman, Richard E ^a   Magram, Jeanne ^b   Eichwald, Ernst J ^c   Bishop, D Keith ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN RECEPTOR; MONOCLONAL ANTIBODY;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; DBA MOUSE; DRUG ANTAGONISM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL MOVEMENT; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; GRAFT REJECTION; HEART TRANSPLANTATION; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; T-LYMPHOCYTES; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030240073     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
2. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
3. Oswald, I. P., P. Caspar, D. Jankovic, T. A. Wynn, E. J. Pearce, and A. Sher. 1994. IL-12 inhibits Th2 cytokine responses induced by eggs of Schistosoma mansoni. J. Immunol. 153:1707.
4. Pearlman, E., F. P. Heinzel, F. E. Hazlett, Jr., and J. W. Kazura. 1995. IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi. J. Immunol. 154:4658.
5. Gazzinelli, R. T., N. A. Giese, and H. C. Morse, III. 1994. In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during acquired immunodeficiency syndrome (MAIDS). J Exp. Med. 180:2199.
6. Fitch, F. W., M. D. McKisic, D. W. Lancki, and T. F. Gajewski. 1993. Differential regulation of murine T lymphocytes subsets. Annu. Rev. Immunol. 11:29.
7. + T cells. Annu. Rev. Immunol. 12:635.
8. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
9. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
10. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172.
11. + T lymphocytes. J. Immunol. 155:111.
12. Via, C. S., V. Rus, M. K. Gately, and F. D. Finkelman. 1994. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J. Immunol. 153:4040.
13. Wynn, T. A., D. Jankovic, S. Hieny, K. Zioncheck, P. Jardieu, A. W. Cheever, and A. Sher. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154:3999.
14. Ghalib, H. W., J. A. Whittle, M. Kubin, F. A. Hashim, A. M. El-Hassan, K. H. Grabstein, G. Trinchieri, and S. G. Reed. 1995. IL-12 enhances Th1-type responses in human Leishmania donovani infections. J. Immunol. 154:4623.
15. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, and E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C. B-17 mice. J. Immunol. 152:1883.
16. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
17. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccetti, S. F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153:5167.
18. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
19. Wynn, T. A., D. Jankovic, S. Hieny, A. W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154:4701.
20. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
21. Leonard, J. P., K. E. Waldburger, and S. J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381.
22. Hall, S. S. 1995. IL-12 at the crossroads. Science 268:1432.
23. Gillessen, S., D. Carvajal, P. Ling, F. J. Podlaski, D. L. Stremlo, P. C. Familletti, U. Gubler, D. H. Presky, A. S. Stern, and M. K. Gately. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25: 200.
24. Ling, P., M. K. Gately, U. Gubler, A. S. Stern, P. Lin, K. Hollfelder, C. Su, Y-C. E. Pan, and J. Hakimi. 1995. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:116.
25. Hall, B. M. 1991. Cells mediating allograft rejection. Transplantation 51:1141.
26. Rosenberg, A. S., and A. Singer. 1992. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 10:333.
27. Charlton, B., H. Auchincloss, and C. G. Fathman. 1994. Mechanisms of transplantation tolerance. Annu. Rev. Immunol. 12:707.
28. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4:471.
29. Corry, R. J., H. J. Winn, and P. S. Russell. 1973. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16:343.
30. Gately, M. K., D. M. Carvajal, S. E. Connaughton, S. Gillessen, R. R. Warrier, K. D. Kolinsky, V. L. Wilkinson, C. M. Dwyer, G. F. Higgins Jr., F. J. Podlaski, D. A. Faherty, P. C. Familletti, A. S. Stern, and D. H. Presky. 1996. IL-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann. NY Acad. Sci. In press.
31. Morgan, C. J., C. J. Hernandez, J. S. Ward, and C. G. Orosz. 1993. Detection of cytokine mRNA in vivo by polymerase chain reaction: problems and solutions. Transplantation 56:437.
32. Bishop, D. K., and C. G. Orosz. 1989. Limiting dilution analysis for alloreactive, TCGF-secreting T cells: two related LDA methods that discriminate between unstimulated precursor T cells and in vivo-alloactivated T cells. Transplantation 47:671.
33. Glasebrook, A. L., and F. W. Fitch. 1980. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J. Exp. Med 151:876.
34. Orosz, C. G., B. Horstemeyer, N. E. Zinn, and D. K. Bishop. 1989. Development and evaluation of a limiting dilution analysis technique that can discriminate in vivo alloactivated cytotoxic T lymphocytes from their naive CTL precursors. Transplantation 47:189.
35. Farrar, J. J., J. Fuller-Farrar, P. L. Simon, M. L. Hilfiker, B. M. Stadler, and W. L. Farrar. 1980. Thymoma production of T cell growth factor (interleukin 2). J. Immunol. 125:2555.
36. Ryser, J. E., and H. R. MacDonald. 1979. Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J. Immunol. 122:1691.
37. MacDonald, H. R., J-C. Cerottini, J-E. Ryser, J. L. Maryanski, C. Taswell, M. B. Widmer, and K. T. Brunner. 1980. Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol. Rev. 51:93.
38. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
39. + T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 59:1155.
40. Bishop, D. K., R. M. Ferguson, and C. G. Orosz. 1990. Differential distribution of antigen-specific helper T cells and cytotoxic T cells after antigenic stimulation in vivo: a functional study using limiting dilution analysis. J. Immunol. 144:1153.
41. Lowry, T. P. 1993. Immunosuppression and selective T-helper subset function: transplant. Science 3:190.
42. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
43. Heinzel, F. P., R. M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730.
44. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan. R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med 170:827.
45. Robertson, M. J., R. J. Soiffer, S. F. Wolf, T. J. Manley, C. Donahue, D. Young, S. H. Herrmann, and J. Ritz. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med 175:779.
46. Krams, S. M., D. A. Falco, J. C. Villanueva, J. Rabkin, S. J. Tomlanovich, F. Vencenti, W. J. C. Amend, J. Melzer, M. R. Garovoy, J. P. Roberts, N. L. Ascher, and O. M. Martinez. 1992. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 53:151.
47. Martinez, O. M., J. C. Villanueva, J. Lake, J. P. Roberts, N. L. Ascher, and S. M. Krams. 1993. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation 55:1159.
48. Martinez, O. M., N. L. Ascher, L. Ferrell, J. Villanueva, J. Lake, J. P. Roberts, and S. M. Krams. 1993. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation 55:909.
49. Jayaraman, S., A. Heiligenhaus, A. Rodriguez, S. Soukiasian, M. E. Dorf, and C. S. Foster. 1993. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J. Immunol. 151:5777.
50. De Wit, D., M. Van Mechelen, C. Zanin, J-M. Doutrelepont, T. Velu, C. Gerard, D. Abramowicz, J-P. Scheerlinck, P. De Baetselier, J. Urbain, O. Leo, M. Goldman, and M. Moser. 1993. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 150:361.
51. Muller, K. M., F. Jaunin, I. Masouye, J-H. Saurat, and C. Hauser. 1993. Th2 cells mediate IL-4-dependent local tissue inflammation. J. Immunol. 150:5576.
52. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulation through induction of IFN-γ. J. Immunol. 155:785.
53. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. Akita, M. Manba, F. Tanabe, K. Konishi, S. Fukuda, and M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88.
54. Kubin, M., J. M. Chow, and G. Trinchieri. 1994. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor α, and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83: 1847.
55. Bogdan, C., and C. Nathan. 1993. Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann. NY Acad. Sci. 685:713.
56. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (1L-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
57. D'Andrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J. Exp. Med. 181:537.
58. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152:1047.